COVID - 19 Vaccination Update - Day 483 - Prevention is better than cure

Spread the Message

Read Time:1 Minute, 40 Second

Posted On: 13 MAY 2022 8:26PM by PIB Delhi

India’s COVID-19 vaccination coverage has crossed 191 Crore landmark milestone (1,91,14,04,078) today. More than 13 lakh (13,21,762) Vaccine Doses have been administered till 7 pm today. The daily vaccination tally is expected to increase with the compilation of the final reports for the day by late tonight.

The cumulative coverage of vaccine doses, segregated based on population priority groups, is as follows:

Cumulative Vaccine Dose Coverage
HCWs	1^st Dose	10406082
	2^nd Dose	10028700
	Precaution Dose	5006469
FLWs	1^st Dose	18417500
	2^nd Dose	17563542
	Precaution Dose	8130418
Age Group 12-14 years	1^st Dose	31502733
	2^nd Dose	11720756
Age Group 15-18 years	1^st Dose	58922207
	2^nd Dose	43821499
Age Group 18-44 years	1^st Dose	556532223
	2^nd Dose	484174801
	Precaution Dose	366721
Age Group 45-59 years	1^st Dose	203127966
	2^nd Dose	189496213
	Precaution Dose	942781
Over 60 years	1^st Dose	127005369
	2^nd Dose	118108677
	Precaution Dose	16129421
Cumulative 1^st dose administered		1005914080
Cumulative 2^nd dose administered		874914188
Precaution Dose		30575810
Total		1911404078

Today’s achievement in the vaccination exercise, segregated by population priority groups, is as follows:

Date: 13^th April, 2022 (483^rd Day)
HCWs	1^st Dose	29
	2^nd Dose	747
	Precaution Dose	12764
FLWs	1^st Dose	67
	2^nd Dose	982
	Precaution Dose	35100
Age Group 12-14 years	1^st Dose	188524
	2^nd Dose	308224
Age Group 15-18 years	1^st Dose	35106
	2^nd Dose	112240
Age Group 18-44 years	1^st Dose	38393
	2^nd Dose	324540
	Precaution Dose	17312
Age Group 45-59 years	1^st Dose	9045
	2^nd Dose	76007
	Precaution Dose	23356
Over 60 years	1^st Dose	5163
	2^nd Dose	50739
	Precaution Dose	83424
Cumulative 1^st dose administered		276327
Cumulative 2^nd dose administered		873479
Precaution Dose		171956
Total		1321762

The vaccination exercise as a tool to protect the most vulnerable population groups in the country from COVID-19 continues to be regularly reviewed and monitored at the highest level.